Cutaneous Anaplastic Large Cell Lymphoma, 6p25.3 (IRF4) Rearrangement, FISH, Tissue
Cutaneous anaplastic large cell lymphoma (pcALCL) is a subtype of T-cell non-Hodgkin lymphoma characterized by large, atypical lymphoid cells with strong CD30 expression. The disease manifests predominantly in the skin, often as solitary or localized nodules, papules, or ulcerated lesions on the trunk, extremities, or head and neck. While these lesions may spontaneously regress, relapse is common. Systemic dissemination is rare compared with systemic ALCL.
The IRF4 (Interferon Regulatory Factor 4, also known as MUM1) gene rearrangement on chromosome 6p25.3 has emerged as a diagnostic marker in pcALCL. IRF4 is a transcription factor important in lymphocyte differentiation, and its rearrangement is highly specific for primary cutaneous ALCL and related CD30-positive lymphoproliferative disorders. Detection of this rearrangement by fluorescence in-situ hybridization (FISH) aids in distinguishing pcALCL from other mimickers, including systemic ALK-negative ALCL, lymphomatoid papulosis, and other cutaneous lymphomas.
- As aid in the diagnosis of cutaneous anaplastic large cell lymphoma
- Aids in differentiation from other cutaneous lymphoproliferative disorders
- Provides prognostic information, as pcALCL generally carries a favorable prognosis
- Therapy monitoring and disease management
Negative
Formalin-fixed, paraffin-embedded (FFPE) tissue blocks or unstained slides (4–6 µm sections).
Stability fixed tissues are stable at room temperature for long time.
- Hum Pathol. 2023 Jul;137:71-78. [PMID: 37127078]
- J Cutan Pathol. 2021 Dec;48(12):1463-1470. [PMID: 34164830]
- Histopathology. 2015 May;66(6):846-55. [PMID: 25131361]
- Am J Dermatopathol. 2023 Dec 1;45(12):831-834. [PMID: 37883980]